.jpg)
- Cancer immunology immunotherapy
-
影響因子：
3.637
-
I S S N：
0340-7004
-
出 版 社：
Springer Verlag
-
出 版 地：
Berlin
-
出版國(guó)家：
Germany
-
刊 期：
月刊
-
創(chuàng)刊時(shí)間：
1982
-
語(yǔ) 種：
英文
-
審稿周期：
平均1月
-
中科院分區(qū)：
2
-
投稿命中率：
較易
-
國(guó)外數(shù)據(jù)庫(kù)收錄：
IM
-
中國(guó)收錄文章數(shù)：
99
-
5年影響因子：
3.554
-
研究領(lǐng)域：
免疫治療、腫瘤
-
官方鏈接：
http://link.springer.com/journal/262
-
投稿須知：
http://link.springer.com/journal/262
期刊介紹：
Keeping readers informed of the latest research results in the fields of oncology and immunology has always been one of the main services provided by Cancer Immunology Immunotherapy. To make this service even more comprehensive the scope of the journal was expanded some years ago to include more of the progres being made in the various fields of biology concerned with biological response modifiers thus enabling readers to keep up to date on the latest advances in our understanding of tumor-host interactions. Tumor immunologists clinical oncologists virologists and medical microbiologists involved in the development of methods of treatment and therapies for cancer patients will have access to the information contained in this journal. The journal publishes short editorials (including "position papers") general reviews original articles and short communications providing a forum for the most recent experimental and clinical advances in tumor immunology.
